These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9184539)

  • 41. Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin?
    Berg JN; Guttmacher AE; Marchuk DA; Porteous ME
    J Med Genet; 1996 Mar; 33(3):256-7. PubMed ID: 8728706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ALK-1 mutations in liver transplanted patients with hereditary hemorrhagic telangiectasia.
    Argyriou L; Pfitzmann R; Wehner LE; Twelkemeyer S; Neuhaus P; Nayernia K; Engel W
    Liver Transpl; 2005 Sep; 11(9):1132-5. PubMed ID: 16123970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia.
    Lebrin F; Mummery CL
    Trends Cardiovasc Med; 2008 Jan; 18(1):25-32. PubMed ID: 18206806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrovascular Manifestations of Hereditary Hemorrhagic Telangiectasia.
    Brinjikji W; Iyer VN; Sorenson T; Lanzino G
    Stroke; 2015 Nov; 46(11):3329-37. PubMed ID: 26405205
    [No Abstract]   [Full Text] [Related]  

  • 45. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.
    Pece-Barbara N; Cymerman U; Vera S; Marchuk DA; Letarte M
    Hum Mol Genet; 1999 Nov; 8(12):2171-81. PubMed ID: 10545596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Supermodels and disease: insights from the HHT mice.
    Shovlin CL
    J Clin Invest; 1999 Nov; 104(10):1335-6. PubMed ID: 10562293
    [No Abstract]   [Full Text] [Related]  

  • 47. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.
    Pece N; Vera S; Cymerman U; White RI; Wrana JL; Letarte M
    J Clin Invest; 1997 Nov; 100(10):2568-79. PubMed ID: 9366572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex.
    Blanco FJ; Santibanez JF; Guerrero-Esteo M; Langa C; Vary CP; Bernabeu C
    J Cell Physiol; 2005 Aug; 204(2):574-84. PubMed ID: 15702480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
    Abdalla SA; Letarte M
    J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hereditary hemorrhagic teleangiectasy].
    Schabel C; Schweinzer K; Ketelsen D; Brechtel K; Horger M
    Rofo; 2012 Feb; 184(2):83-6. PubMed ID: 22274844
    [No Abstract]   [Full Text] [Related]  

  • 51. Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality.
    Torsney E; Charlton R; Diamond AG; Burn J; Soames JV; Arthur HM
    Circulation; 2003 Apr; 107(12):1653-7. PubMed ID: 12668501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor.
    Sorensen LK; Brooke BS; Li DY; Urness LD
    Dev Biol; 2003 Sep; 261(1):235-50. PubMed ID: 12941632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromosomal localization of three human genes encoding members of the TGF-beta superfamily of type I serine/threonine kinase receptors.
    Röijer E; Miyazono K; Aström AK; Geurts van Kessel A; ten Dijke P; Stenman G
    Mamm Genome; 1998 Mar; 9(3):266-8. PubMed ID: 9501322
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetic clues to the cause of primary pulmonary hypertension.
    Loscalzo J
    N Engl J Med; 2001 Aug; 345(5):367-71. PubMed ID: 11484696
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia.
    Kjeldsen AD; Møller TR; Brusgaard K; Vase P; Andersen PE
    J Intern Med; 2005 Oct; 258(4):349-55. PubMed ID: 16164574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France.
    Lesca G; Plauchu H; Coulet F; Lefebvre S; Plessis G; Odent S; Rivière S; Leheup B; Goizet C; Carette MF; Cordier JF; Pinson S; Soubrier F; Calender A; Giraud S;
    Hum Mutat; 2004 Apr; 23(4):289-99. PubMed ID: 15024723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of 17 novel endoglin mutations associated with hereditary hemorrhagic telangiectasia.
    Cymerman U; Vera S; Karabegovic A; Abdalla S; Letarte M
    Hum Mutat; 2003 May; 21(5):482-92. PubMed ID: 12673790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hereditary hemorrhagic telangiectasia].
    Duffau P; Lazarro E; Viallard JF
    Rev Med Interne; 2014 Jan; 35(1):21-7. PubMed ID: 23517771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A murine model of hereditary hemorrhagic telangiectasia.
    Bourdeau A; Dumont DJ; Letarte M
    J Clin Invest; 1999 Nov; 104(10):1343-51. PubMed ID: 10562296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
    Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.